Biotech / Jason Napodano, CFA

Company Ticker

To Access Reports Click on + →

Aastrom Bioscience ASTM

Acadia Pharmaceuticals ACAD

Addex Therapeutics ADXN

Amarantus BioScience Holdings AMBS

Avita Medical Ltd AVMXY

Cipher Pharmaceuticals DND

Cynapsus Therapeutics Inc. CTH

Cytomedix Inc. CMXI

Dara Biosciences DARA

Depomed DEPO

DURECT Corporation DRRX

International Stem Cell ISCO

Invivo Therapeutics NVIV

LabStyle Innovations Corp. DRIO

Neuralstem Inc. CUR

Neurocrine Bioscience NBIX

Omni Bio Pharmaceutical, Inc. OMBP

Organovo Holdings, Inc. ONVO

OxySure Systems, Inc. OXYS

Pozen Inc. POZN

Titan Pharmaceuticals TTNP

Tonix Pharmaceuticals TNXP

Trius Therapeutics TSRX

Zalicus Inc ZLCS

Notes in the Press

June 17, 2013 Amarantus Teams With Becton, Dickinson For LymPro Development, Seeking PD-LID Candidate

June 17, 2013 Avita Medical's Breakthrough Device Nearing U.S. Approval

June 17, 2013 Initiating Coverage of Avita Medical

June 14, 2013 Alkermes Changing The Standard Of Care For Schizophrenia

June 12, 2013 Sanuwave: DermaPACE Could Be Very Competitive In $2B Diabetic Foot Ulcer Market

June 12, 2013 Look for CTS’ Restructuring to Save $8-10 Million

June 10, 2013 LTNC: Expect Positive Sector Dynamics to Enhance Labor Smart’s Ambitious Growth Strategy.

June 10, 2013 CTSO: Tiny Med-Tech With Huge Potential

June 10, 2013 DUMA: Moving forward on Namibia. Aerial survey tender process concluded.

June 10, 2013 UHAL: Transaction growth drives moving revenue to another great quarter.

Login module

User ID:
Password:
Remember my ID:

Register Now

COPYRIGHT © ZACKS INVESTMENT RESEARCH 2011

Follow @ZacksSmallCap

Powered By Q4 Web Systems 3.8.2.5449